Cover Image
市場調查報告書

中國的中醫成藥產業報告

China Chinese Patent Medicine Industry Report, 2013-2016

出版商 ResearchInChina 商品編碼 172262
出版日期 內容資訊 英文 102 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的中醫成藥產業報告 China Chinese Patent Medicine Industry Report, 2013-2016
出版日期: 2014年03月07日 內容資訊: 英文 102 Pages
簡介

中國的中藥產業在2010年到2013年間急速擴大,其收益由2010年的2154億人民幣,擴大到2013年的4482億人民幣,達到CAGR27.7%的成長。

本報告提供中國的中醫成藥產業調查分析,提供產業政策,發展情形,地區市場,進出口,發展趨勢驗證,再加上原料狀況,各分類市場分析,主要企業簡介,為您概述為以下內容。

第1章 中醫成藥概要

  • 定義與機能
  • 分類

第2章 中醫成藥產業的經營環境

  • 政策
  • 消費趨勢
  • 產業趨勢

第3章 中醫成藥產業的市場

  • 發展情形
  • 需求與供給
  • 進出口
  • 需求趨勢
  • 傳統的中藥(TCM)的原料
  • 植物萃取物

第4章 中國的中醫成藥市場區隔

  • 概要
  • 心血管疾病,腦血管疾病
  • 腫瘤性疾病
  • 呼吸系統疾病
  • 肌肉骨骼系統疾病

第5章 中醫成藥主要的製造商

  • Tianjin Tasly Pharmaceutical Co., Ltd.
  • Guizhou Yibai Pharmaceutical Co., Ltd.
  • Yunnan Baiyao Group Co., Ltd.
  • Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
  • Shandong Dong-E E-Jiao Co., Ltd.
  • China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (CR Sanjiu)
  • Shanghai Kaibao Pharmaceutical Co., Ltd.
  • Kangmei Pharmaceutical Co., Ltd.
  • Tibet Rhodiola Pharmaceutical Holding Co., Ltd.
  • Beijing Tongrentang Co., Ltd. (TRT)

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: ZZR-001

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance with specified prescription and standard. Chinese patent medicine industry covers the upstream Chinese herbal medicine production and preliminary processing, the middle pharmaceutical sectors as well as downstream commercial institutions of drug circulation and sales.

Currently, the State is enhancing its support for the Chinese patent medicine industry, successively introducing the Continuing Improving TCM Healthcare Policy, Notice on Conducting Construction of Key Projects of TCM Trade in Services and other favorable policies in 2013. In 2010-2013, China's Chinese patent medicine industry developed rapidly, with revenue soaring from RMB215.4 billion to RMB448.2 billion at a CAGR of 27.7%.

According to hospital terminal data, Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases, tumor diseases and respiratory system diseases are the top three categories of Chinese patent medicine in China, respectively accounting for 37.2%, 15.4% and 11.1% market share in 2012-2013. As far as the distribution of Chinese patent medicine formulations is concerned, there is a clear trend of convergence in injection, and injection formulation products in the top three categories of Chinese patent medicine all made up above 50%.

Cardiovascular and cerebrovascular disease market is the biggest market for Chinese patent medicine, but also the most-variety field with item sales of over RMB500 million. The representative products include ginkgo leaf injection, Shuxuetong injection, Danhong injection, Xingnao injection, and more.

Demand Structure of Chinese Patent Medicine by disease or dosage forms

Source: China Chinese Patent Medicine Industry Report,
2013-2016, ResearchInChina

In the international market, there is a higher recognition of Chinese patent medicine in Asia, especially in Southeast Asia, and many varieties of Chinese patent medicine are included in the Medicare drug list stipulated by Southeast Asian countries, and special departments are established for management research as well. But in the U.S. and European markets, affected by access restrictions and differences in medical health concept, Chinese patent medicine is still only sold as health care product. However, the international market sees strong demand for plant extracts (mostly traditional Chinese medicinal materials) whose export value in 2010-2013 grew at a CAGR of 44% and accounted for approximately 50% of China's TCM export value.

China Chinese Patent Medicine Industry Report, 2013-2016 mainly covers the followings:

  • Introduction to China's Chinese patent medicine industry chain as well as domestic and foreign policies, consumer trends and industry trends;
  • Development situation, supply and demand, import and export, regional analysis, industry chain segments, etc. of Chinese patent medicine industry;
  • China's Chinese patent medicine market segments, involving Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases, tumor diseases, etc.;
  • Profile and analysis, development prospect and earnings forecast, industry trends and market forecast of key Chinese patent medicine manufacturers in China.

Table of Contents

1. Overview of Chinese Patent Medicine

  • 1.1. Definition and Characteristics
  • 1.2. Classification
    • 1.2.1. Classification by Dosage Form
    • 1.2.2. Classification by Pharmacology
    • 1.2.3. Industry Chain

2. Operating Environment for Chinese Patent Medicine Industry

  • 2.1. Policies
    • 2.1.1. Domestic Policies
    • 2.1.2. Foreign Policies
  • 2.2. Consumer Trends
  • 2.3. Industry Trends

3. Chinese Patent Medicine Market

  • 3.1. Development Status
  • 3.2. Demand
    • 3.2.1. Regional Demand
    • 3.2.2. Product Demand Structure
    • 3.2.3. Trends
  • 3.3. Supply
    • 3.3.1. Yield Analysis and Key Areas
    • 3.3.2. Industry Concentration
  • 3.4. Regional Analysis of Players
  • 3.5. Import and Export
    • 3.5.1. Import
    • 3.5.2. Export
    • 3.5.3. Import-Export Structure
  • 3.6. Traditional Chinese Medicinal Materials
    • 3.6.1. Resources
    • 3.6.2. Price Trend
  • 3.7. Traditional Chinese Medicine Decoction Pieces (Chinese Herbal Medicines for Primary Processing)
    • 3.7.1. Industry Status
    • 3.7.2. Industry Trends
  • 3.8. Plant Extract
    • 3.8.1. Development Status
    • 3.8.2. Import and Export

4. Chinese Patent Medicine Market Segments in China

  • 4.1. Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases
  • 4.2. Chinese Patent Medicine for Tumor Diseases
  • 4.3. Chinese Patent Medicine for Respiratory System Diseases
  • 4.4. Chinese Patent Medicine for Musculoskeletal Diseases

5. Key Enterprises

  • 5.1. Tianjin Tasly Pharmaceutical Co., Ltd.
    • 5.1.1. Profile
    • 5.1.2. Operation
    • 5.1.3. Revenue Structure
    • 5.1.4. Gross Margin
    • 5.1.5. Prospects
  • 5.2. Guizhou Yibai Pharmaceutical Co., Ltd.
    • 5.2.1. Profile
    • 5.2.2. Operation
    • 5.2.3. Revenue Structure
    • 5.2.4. Gross Margin
    • 5.2.5. Prospects
  • 5.3. Yunnan Baiyao Group Co., Ltd.
    • 5.3.1. Profile
    • 5.3.2. Operation
    • 5.3.3. Revenue Structure
    • 5.3.4. Gross Margin
    • 5.3.5. Prospects
  • 5.4. Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
    • 5.4.1. Profile
    • 5.4.2. Operation
    • 5.4.3. Revenue Structure
    • 5.4.4. Gross Margin
    • 5.4.5. Prospects
  • 5.5. Shandong Dong-E E-Jiao Co., Ltd.
    • 5.5.1. Profile
    • 5.5.2. Operation
    • 5.5.3. Revenue Structure
    • 5.5.4. Gross Margin
    • 5.5.5. Prospects
  • 5.6. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (CR Sanjiu)
    • 5.6.1. Profile
    • 5.6.2. Operation
    • 5.6.3. Revenue Structure
    • 5.6.4. Gross Margin
    • 5.6.5. Prospects
  • 5.7. Shanghai Kaibao Pharmaceutical Co., Ltd.
    • 5.7.1. Profile
    • 5.7.2. Operation
    • 5.7.3. Revenue Structure
    • 5.7.4. Gross Margin
    • 5.7.5. Prospects
  • 5.8. Kangmei Pharmaceutical Co., Ltd.
    • 5.8.1. Profile
    • 5.8.2. Operation
    • 5.8.3. Revenue Structure
    • 5.8.4. Gross Margin
    • 5.8.5. Prospects
  • 5.9. Tibet Rhodiola Pharmaceutical Holding Co., Ltd.
    • 5.9.1. Profile
    • 5.9.2. Operation
    • 5.9.3. Revenue Structure
    • 5.9.4. Gross Margin
    • 5.9.5. Prospects
  • 5.10. Beijing Tongrentang Co., Ltd. (TRT)
    • 5.10.1. Profile
    • 5.10.2. Operation
    • 5.10.3. Revenue Structure
    • 5.10.4. Gross Margin
    • 5.10.5. Prospects

6. Summary and Forecast

  • 6.1. Comparison of Domestic Key Chinese Patent Medicine Enterprises
    • 6.1.1. Revenue
    • 6.1.2. Gross Margin
  • 6.2. Industry Forecast
    • 6.2.1. Industry Trends
    • 6.2.2. Market Forecast

Selected Charts:

  • Advantages and Disadvantages of Chinese Patent Medicine
  • Classification of Chinese Patent Medicine by Dosage Form
  • Classification of Chinese Patent Medicine by Pharmacology
  • Chinese Patent Medicine Industry Chain
  • Recent National Policies on Chinese Patent Medicine
  • Chinese herbal medicine production support projects, 2013
  • Percentage of Chinese Patent Medicine Output Value in Total Output Value of Pharmaceutical Industry, 2009-2012
  • Number of Chinese Patent Medicine Enterprises in China, 2010-2013
  • Revenue and YoY Growth Rate of Chinese Patent Medicine Industry in China, 2010-2013
  • Total Profit and YoY Growth Rate of Chinese Patent Medicine Industry in China, 2010-2013
  • Gross Margin of Chinese Patent Medicine Enterprises in China, 2012-2013
  • China's Top 7 Regions by Chinese Patent Medicine Sales, 2012
  • China's Chinese Patent Medicine Sales Structure by Top 7 Regions, 2012
  • China's Chinese Patent Medicine Hospital Terminal Sales Structure by Type of Diseases Treated, 2012
  • Revenue and Share in Pharmaceutical Industry of China's Chinese Patent Medicine Industry, 2010-2013
  • China's Population Aged 65 and Above, 2002-2013
  • Per Capita Healthcare Expenditure of China's Urban and Rural Residents, 2002-2012
  • Average Annual Air Pollution Index in Some Key Cities Nationwide, 2013
  • Output and YoY Growth Rate of Chinese Patent Medicine in China, 2010-2013
  • China's Top 5 Regions by Chinese Patent Medicine Output, 2013
  • Market Share Ranking of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases
  • Market Share Ranking of Chinese Patent Medicine for Tumor Diseases
  • Market Share Ranking of Chinese Patent Medicine for Musculoskeletal Diseases
  • Market Share Ranking of Gynecological Products
  • Top 10 Chinese Provinces/Municipalities by Number of Above-scale Chinese Patent Medicine Enterprises, 2012
  • Top 10 Chinese Provinces/Municipalities by Sales of Chinese Patent Medicine Enterprises, 2012
  • Chinese Provinces/Municipalities with Gross Margin of Chinese Patent Medicine Enterprises Above 40%, 2012
  • Number of Enterprises, Sales and Total Profit of China's Chinese Patent Medicine Market by Region, 2012
  • China's Chinese Patent Medicine Import Value and YoY Growth Rate, 2010-2013
  • China's Traditional Chinese Medicinal Materials and Traditional Chinese Medicine Decoction Pieces Import Value and YoY Growth Rate, 2010-2013
  • China's Plant Extract Import Value and YoY Growth Rate, 2010-2013
  • China's Chinese Patent Medicine Export Value and YoY Growth Rate, 2010-2013
  • China's Traditional Chinese Medicinal Materials and Traditional Chinese Medicine Decoction Pieces Export Value and YoY Growth Rate, 2010-2013
  • China's Plant Extract Export Value and YoY Growth Rate, 2010-2013
  • Proportion of Export Value of China's Plant Extracts in TCM Commodities, 2010-2013
  • TCM Commodities Export Value by Region, Jan-Sep 2013
  • China's Top 10 Chinese Patent Medicine Exporting Enterprises, 2011
  • China's Top 5 Chinese Patent Medicine Exporting Enterprises, 2012
  • Trade Gap between China's Chinese Patent Medicine Imports and Exports, 2010-2013
  • Proportion of China's Plant Extract Export Value, 2010-2013
  • Trend Chart of Traditional Chinese Medicinal Material Comprehensive 200 Index, 2007-2013
  • Price Index of Traditional Chinese Medicinal Materials in Chengdu, China, 2010-2013
  • Major Traditional Chinese Medicinal Material GAP Enterprises in China, 2012
  • Revenue and Net Income of Traditional Chinese Medicine Decoction Pieces Industry, 2010-2013
  • China's Plant Extract Export Destination Structure by Export Value, 2012
  • Four Major Series of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases
  • Share of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2008-2012
  • Distribution of Dosage Forms of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases, 2012
  • Excellent Brands of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases, 2012
  • Share of Chinese Patent Medicine for Tumor Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2008-2012
  • Distribution of Dosage Forms of Chinese Patent Medicine for Tumor Diseases in Some Key Cities, 2012
  • Top 10 Excellent Brands of Chinese Patent Medicine for Tumor Diseases in China, 2012
  • Share of Chinese Patent Medicine for Respiratory System Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2008-2012
  • Chinese Patent Medicine for Respiratory System Diseases in Sample Hospital by Type, 2012
  • Excellent Brands of Chinese Patent Medicine for Respiratory System Diseases, 2012
  • Share of Chinese Patent Medicine for Musculoskeletal Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2008-2012
  • Distribution of Dosage Forms of Chinese Patent Medicine for Musculoskeletal Diseases in Sample Hospital, 2012
  • China's Top 10 Excellent Brands of Traditional Chinese Medicine for Musculoskeletal Diseases, 2012
  • Revenue and Net Income of Tasly, 2010-2013
  • Revenue Breakdown of Tasly by Sector, 2010-2013
  • Revenue Breakdown of Tasly by Region, 2010-2013
  • Gross Margin of Tasly by Sector, 2010-2013
  • Gross Margin of Tasly by Region, 2010-2013
  • Revenue and Net Income of Tasly, 2012-2016E
  • Revenue and Net Income of Yibai Pharmaceutical, 2010-2013
  • Revenue Breakdown of Yibai Pharmaceutical by Product, 2010-2013
  • Gross Margin of Yibai Pharmaceutical by Product, 2010-2013
  • Revenue and Net Income of Yibai Pharmaceutical, 2012-2016E
  • Revenue and Net Income of Yunnan Baiyao, 2010-2013
  • Revenue Breakdown of Yunnan Baiyao by Product, 2010-2013
  • Revenue Breakdown of Yunnan Baiyao by Region, 2010-2013
  • Gross Margin of Yunnan Baiyao by Product, 2010-2013
  • Gross Margin of Yunnan Baiyao by Region, 2010-2013
  • Revenue and Net Income of Yunnan Baiyao, 2012-2016E
  • Revenue and Net Income of Pien Tze Huang, 2010-2013
  • Revenue Breakdown of Pien Tze Huang by Sector, 2010-2013
  • Revenue Breakdown of Pien Tze Huang by Region, 2010-2013
  • Gross Margin of Pien Tze Huang by Product, 2010-2013
  • Gross Margin of Pien Tze Huang by Region, 2010-2013
  • Revenue and Net Income of Pien Tze Huang, 2012-2016E
  • Revenue and Net Income of Dong-E E-Jiao, 2010-2013
  • Revenue Breakdown of Dong-E E-Jiao by Product, 2010-2013
  • Revenue Breakdown of Dong-E E-Jiao by Region, 2010-2013
  • Gross Margin of Dong-E E-Jiao by Product, 2010-2013
  • Gross Margin of Dong-E E-Jiao by Region, 2010-2013
  • Revenue and Net Income of Dong-E E-Jiao, 2012-2016E
  • Revenue and Net Income of CR Sanjiu, 2010-2013
  • Revenue Breakdown of CR Sanjiu by Sector, 2010-2013
  • Revenue Breakdown of CR Sanjiu by Product, 2010-2013
  • Gross Margin of CR Sanjiu by Sector, 2010-2013
  • Revenue and Net Income of CR Sanjiu, 2012-2016E
  • Revenue and Net Income of Shanghai Kaibao, 2010-2013
  • Revenue Breakdown of Shanghai Kaibao by Product, 2010-2013
  • Revenue Breakdown of Shanghai Kaibao by Region, 2010-2013
  • Gross Margin of Shanghai Kaibao by Product, 2010-2013
  • Revenue and Net Income of Shanghai Kaibao, 2012-2016E
  • Revenue and Net Income of Kangmei Pharmaceutical, 2010-2013
  • Revenue Breakdown of Kangmei Pharmaceutical by Product, 2010-2013
  • Gross Margin of Kangmei Pharmaceutical by Product, 2010-2013
  • Revenue and Net Income of Kangmei Pharmaceutical, 2012-2016E
  • Revenue and Net Income of Tibet Rhodiola Pharmaceutical, 2010-2013
  • Revenue Breakdown of Tibet Rhodiola Pharmaceutical by Product, 2010-2013
  • Revenue Breakdown of Tibet Rhodiola Pharmaceutical by Region, 2010-2013
  • Gross Margin of Tibet Rhodiola Pharmaceutical by Product, 2010-2013
  • Gross Margin of Tibet Rhodiola Pharmaceutical by Region, 2010-2013
  • Revenue and Net Income of Tibet Rhodiola Pharmaceutical, 2012-2016E
  • Revenue and Net Income of Tongrentang, 2010-2013
  • Revenue Breakdown of Tongrentang by Region, 2010-2013
  • Gross Margin of Tongrentang by Region, 2010-2013
  • Revenue and Net Income of Tongrentang, 2012-2016E
  • Revenue of Some Key Chinese Patent Medicine Enterprises in China, Jan-Sep 2013
  • Gross Margin of Some Key Chinese Patent Medicine Enterprises in China, Jan-Jun 2013
  • Revenue of Chinese Patent Medicine Industry in China, 2013-2016E
Back to Top